South Korea Clinical Nutrition Market Size, Share, and COVID-19 Impact Analysis, By Product (Parenteral, Enteral, and Oral), By Application (Malabsorption/GI Disorder/Diarrhea and Cancer Care), By Sales Channel (Institutional Sales Channels, Retail Sales Channels, and Online Sales Channels), and South Korea Clinical Nutrition Market, Industry Trend, Forecasts to 2035

South Korea Clinical Nutrition Market Insights Forecasts to 2035

• The South Korea Clinical Nutrition Market Size Was Estimated at USD 820.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.61% from 2025 to 2035
• The South Korea Clinical Nutrition Market Size is Expected to Reach USD 1658.2 Million by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Clinical Nutrition Market Size is anticipated to reach USD 1658.2 Million by 2035, growing at a CAGR of 6.61% from 2025 to 2035. The market's expansion is the rising prevalence of malnutrition. Over the past few years, there has been a notable increase in the number of elderly individuals suffering from serious illnesses. Due to a variety of age-related changes in body composition and muscle mass, older adults with comorbid conditions including stroke, depression, and dementia, are far more likely to suffer from malnutrition and frailty.

Market Overview

The market for clinical nutrition includes the sector that focuses on offering specialist nutritional support, both in the form of goods and services, to people with medical disorders.  In order to meet the needs of individual patients and enhance therapeutic results, it focuses on the prevention, diagnosis, and treatment of nutritional and metabolic problems using specialized dietary interventions, such as enteral and parenteral nutrition. Through dietary changes, clinical nutrition plays a critical role in controlling and possibly reversing the symptoms of chronic diseases such as diabetes, heart disease, and cancer.  Encouraging wholesome eating practices and offering prophylactic nutritional advice it also aids in the prevention of various illnesses. The market is growing as a result of the increased prevalence of chronic illnesses like diabetes, cancer, and cardiovascular diseases, which frequently call for specific nutritional support. Regulations about food safety and manufacturing procedures are among those that apply to the clinical nutrition sector.  These rules guarantee the safety and effectiveness of clinical nutrition products, even though they occasionally make it more difficult to enter new markets and develop new products.

Report Coverage

This research report categorizes the market for South Korea clinical nutrition market based on various segments and regions forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea clinical nutrition market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea clinical nutrition market.

Driving Factors

The increasing prevalence of chronic diseases such as diabetes, cancer, and gastrointestinal disorders has heightened the demand for specialized nutritional interventions to support recovery and improve patient outcomes. Advancements in medical technology, including personalized nutrition solutions and medical nutrition therapy, enable tailored dietary plans that address individual health needs.

Restraining Factors

High costs of specialized nutritional products and therapies limit accessibility, particularly in low-income regions. Additionally, lack of awareness and education among healthcare providers and patients about clinical nutrition benefits restricts market adoption.

Market Segmentation

The South Korea clinical nutrition market share is classified into product, application, and sales channels.

• The parenteral segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea clinical nutrition market is segmented by product into parenteral, enteral, and oral. Among these, the parenteral segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The industry is expanding due to a number of causes, including the development of technically sophisticated parenteral nutrition (PN) products with barcode help, patients' increasing preference for PN over enteral nourishment, shorter hospital stays, and a lower risk of infection.

• The malabsorption/GI disorder/diarrhea segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea clinical nutrition market is segmented by application into malabsorption/GI disorder/diarrhea, and cancer care. Among these, the malabsorption/GI disorder/diarrhea segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Generally speaking, malabsorption refers to problems with the digestion of nutrients obtained from diet.  Malabsorption has been linked to several illnesses, including Crohn's disease, short bowel syndrome, cystic fibrosis, and chronic pancreatitis.  If the body does not receive the right nutrients, it can also result in other diseases.

• The institutional sales channels services segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea clinical nutrition market is segmented by sales channel into institutional sales channels, retail sales channels, and online sales channels. Among these, the institutional sales channels segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. Hospitals, long-term care facilities, hospices, and facilities for people with disabilities are among the organizations that buy clinical nutrition products.  Physicians have a say in whether enteral or parenteral nourishment is purchased.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea clinical nutrition market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• NUCARE (Daesang Wellife)
• CJ CheilJedang
• Pulmuone
• Sahmyook Foods
• Green Cross (GC Biopharma)
• Samsung Biologics
• Korea Ginseng Corporation (Cheong Kwan Jang)
• Amway Korea
• Herbalife Korea
• USANA Korea
• Nestle Health Science Korea
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea clinical nutrition market based on the below-mentioned segments:

South Korea Clinical Nutrition Market, By Product

• Parenteral
• Enteral
• Oral

South Korea Clinical Nutrition Market, By Application

• Malabsorption/GI Disorder/Diarrhea
• Cancer Care

South Korea Clinical Nutrition Market, By Sales Channel

• Institutional Sales Channels
• Retail Sales Channels
• Online Sales Channels